Ipca Labs Q2 Profit Up 23% to Rs 283 Cr
x
Ipca Labs reports Q2 net profit of Rs 283 crore, a 23% increase YoY. Revenue rises to Rs 2,556 crore. Stock closes down 2.92% on BSE.
New Delhi, Nov 13 (PTI) Ipca Laboratories on Thursday posted a 23 per cent year-on-year increase in consolidated net profit at Rs 283 crore for the second quarter ended September 30, 2025.
The drug firm reported a net profit of Rs 229 crore for the July-September period of the last fiscal.
Revenue from operations rose to Rs 2,556 crore for the second quarter, as against Rs 2,355 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
Shares of the company closed 2.92 per cent down at Rs 1,302.70 apiece on BSE.
The drug firm reported a net profit of Rs 229 crore for the July-September period of the last fiscal.
Revenue from operations rose to Rs 2,556 crore for the second quarter, as against Rs 2,355 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
Shares of the company closed 2.92 per cent down at Rs 1,302.70 apiece on BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone-Idea-L
- 10.29 ( -4.72)
- 71162549
- Spicejet-Ltd
- 32.50 (+ 4.47)
- 59158929
- Alstone-Textiles
- 0.30 ( 0.00)
- 37245425
- Sunshine-Capital
- 0.25 ( 0.00)
- 25623281
- G-V-Films
- 0.63 ( -4.55)
- 21918363
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback